This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Samaya Krishnan: Innovator in Cancer Therapy
Introduction
Samaya Krishnan is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on the targeting of PELP1, a protein involved in oncogenic signaling in cancers.
Latest Patents
Samaya Krishnan holds 1 patent for his invention titled "Targeting of PELP1 in cancer therapy." This patent describes PELP1 binding peptides and peptoids, which are utilized to interact with molecules that lead to oncogenic signaling in various cancers. This groundbreaking work has the potential to advance therapeutic strategies in oncology.
Career Highlights
Samaya is affiliated with the University of Texas System, where he conducts his research. His position at this esteemed institution allows him to collaborate with other leading scientists and contribute to the advancement of cancer research.
Collaborations
Some of his notable coworkers include Ratna K Vadlamudi and Monica Mann. Their collaborative efforts enhance the research environment and foster innovation in cancer therapy.
Conclusion
Samaya Krishnan's work in targeting PELP1 represents a significant advancement in cancer therapy. His contributions to the field are paving the way for new treatment options and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile